SNTG1

syntrophin gamma 1, the group of PDZ domain containing

Basic information

Region (hg38): 8:49909789-50796692

Links

ENSG00000147481NCBI:54212OMIM:608714HGNC:13740Uniprot:Q9NSN8AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SNTG1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SNTG1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
6
clinvar
1
clinvar
7
missense
24
clinvar
4
clinvar
1
clinvar
29
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
2
3
non coding
2
clinvar
2
clinvar
4
Total 0 0 24 12 4

Variants in SNTG1

This is a list of pathogenic ClinVar variants found in the SNTG1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
8-50314667-TCTTCTTTATGTTATTTCATGAATCTGAAATGATCTATATCACCCCTTCCTTTACCCCATGTCGAAATGTAAATGATAATTATAGGACAATTTCAAATTTTATTTCTTTTAAAAGATTTGTGTAATCTCCCCAGTTAAATGTGACCTCTTCCAACTCTGCATTTGGCTTATGCCTCTTTTGAGCACTTTTACTTTACCTAGTGTTGTAAGCACTGGTGAACTTTTCTGTCTACTAGGTGATCATTACCTTGAGAGCAAGACAATGTGTTACAGTTTTTACGCCCCTTATGGTACTGGTTCTAACTATAGTGTTTTGATAGATTGACAGCATTAAACTCATTGATTATAATTTATTTATTAAATAATTCATCAAAAAATTAATTACTAAATATTGCGAATGGATTGCCTTATTTTAAAAAATGAATTTAAAAAGTCATTTAACTCTGTTATAATATTCTTGTATATATATTATTTATAATTTCTGAAATGCAAGATAAGGGATAGAGCTGCAGTGGTCACTGAGGAATGTTAATTTATCTTCAGTTTGTTATGTCTATGGTGCAGCGTTCAATGCAATTCAATTTTATTTCCCATATGTTGGCTACGGAAAAGGAACAATATCATTGCTTTACTGGAGCTAATGGGAGATAATTTATATGTTGATATGAGTAACTACTTTTAAATTTACTTCATAAATACCTTAGTAGCATTCAAATTTTGTATGAACTTTATTGGCATTCCCCACAAATTATATAGTGTATAGTAAAAGAAATAAAAAATAACTGTATTGATCATATTATGCAACATTGTTGAGAACTATTTAAGAGTAGATAAAAAATAAAATGTTAGATATAATGAACTAATACTATAGGTAGTGAAAATGATAGTGGAGAATCATATTGAAATGTTGAGTGGAATGACAAAATGCAGATTGCTTCAATAAAGCAGAAAACCTGCAGTGTAGAACTAAAATGAAGCATACTTCAAGTATGTAGTGATTCTAAGAATGTTTTCTTTCTCTTGGACACTTATAGTGAATATGCCTTCCTAACAATCTTTCATTCAAAACCATTGAAAAGAAAAACATACTAATACTAAGGATGCAAACCATCAAAGCTCTGCTATTGTTATTCCCACCATGAACACCTGCACTGCAATCAAGCACAATTCACAGATGTGAGCTGAAAGTGTGCTGATAAGCACATGTCTACCTTTCAGATTTTCATTGAATAAATACTACCTGGAAGTTCAGAAAAGTGGAAATTGAATGTGAGAAGACTTCACTCAAAAAAGAAAAATCTCTCAAATGTTTTTCCCCATTTTTTGATTCATATCACATTTCAGTTGCTTTTCAAGAAACCAACTTTTAAAATTCTACTTTTTTCTACAGACATCATGTGACATGGTAATTTAATTAACATCATTATTCTTTCATTTATATTTAATCTTATCTCTCAGTCTTGTCACTGCAAGTGATCAATTCAAAACATTTAAAAACAATGAGGTAAAATACAATAAACTTGTACAGATTTTCCTAGCTTACAGAATTTGGTAAACACGGTAGAATCCATGATGATGCCAGAGCACATTTGTTAGAAAAAAAAGTTTCAGTTTGATCATGAAAGTTGGGTGCATATTCTCCATCTCCTATGATGTCATACCGTGTGACCACAATCATGTCTACTTAATTCATTTTGGATGTTTTGATGTACTTGAATTTAGAACACGTCTGTCGGAAAGAGGAATTAGTGCCTTTACTAATGTTACCATTTTAAAATATGACAAAACCTAATTAAGAGTACTGCAAGTTATTGAAACATTCTTTATGTGGCTTTTTGTTTGGTCACTCTATTATATAGCAAATCTGTCCAAAGAATGGAACTTATAAAGAAATTTTAAAATAATTTCATTTTCTGCTGATGGCAACCTTTTTATGACCTAGGCCATATGACAAAGAATACACTTAATAATTCAGCAAATGATGAGAAACTAATATGTTCCAAGCAGTCCAGTTAGTACTAAGGATGTAATTCTAATCTAGATAAGTATACAGTTGATTGCAGAGAGATATGTACATAGATAATACAATGAGAACTTGTAAACACAATAAGAGTATGCAATCAACAAATACATATTGAACAACCACTATGTCCCAAGCACTGTGCTGAAATTTACATACGCCAAAATTCCAGTAATAGTGGAACAATATTTCTACTGGAAAATGTTTAAAAAAATTTATAGAGATAGTACTTAATCTGCATTTTGAAGATAAATATGTTTTTAAATGAAGATGAGTTCAAGATTTCACTGCTAAAGAAGCAATGATTATAAAGGTCTAAGCTGAATCTAGATTTAAAAAGTAGTGAGTGATTGTCACTGAAGCCCAAGATAAATGGGGAGGAGAAGGAAAAGCTATTGGAGGTGCTTTTGATAAATATCTGGTAGATTCCTTAGGGGGATTATTTCCTTTAAGAGAAATTTGGTAATCTCATTAGCCTTTTCTGTTCTGGGAGGGTAAGCTTCAACCCAGCCCATAGAGGTCTCTACTAGTATTAGCAAAAACTTGTATCCTTTGCAAGCTGGCATGTAGGTGAAGTCTAATTGCCAGGTGACATAGTTTGTCCAGAACAATACTGATTATATGACTATTTCTGAAATCATGATTAACAGTGTCCCTTTTCACTCCCAAAAGTTTCTTTGGTCTGAAGATAAAGTGCAAGGTTATTTTCTATAGAAAAGTTAACTTACAGAGTTCTACACATCAGCCCTTTAGCAACAGTAAACAGCAGAAGACTCTAAGTGGAAAAGTAATGCACATGCCTATCCTTAAAGATAATCCTGGCAGCAATGTGAAGAATAGTCAGGAATGAGACTGAAACAGGATGATGGTGTATGAAACGTGTTAGCACAAACAGAAACAAAGGAGTTTGAATTAGAGCAATGCAAGTGGGAAGGAGAGGAATCCTACCATAGGAAGAATTTGGTCTTTTTCATGTCTTCTCTGGAAAAGAGCTAGAACACATTCTTACTTTCCTTTTCTTCTCTGTGTCCTTATGACATCGTTTGCCTATTCATGACATCTTGAACTCATCTTCATTTAACAACATATTTACCTTTCAAAATGCAGATTAAGTACTATCTCTATGACATCACTTATTGTCTGAGTTGTTTTTTTGTTTGTTTGTTTTGAGACAGAGTCTCGCTCTGTCGCCCAGGCTTGAGTGCAGTGGCGCAATCTCTGCTCACTGCAAGCTCCGCCTCCCGGGTTCACGCCATTCTCCTGCCTCAGCATCCCCAGTAGCTGGGACTACAGGCGCTCGCCACCACGCCCGGCTAATTTTTTGTATTTTTAGTAGACACGGGGTTTCACCATGTTAGCCAGGAAGGTCTCGATCTCCTGACCTCGTGATCCGCCCGCCTTGACCTCCCAAAGTGCTGGGATTACAGGCGTGAGCCACCGAGCCCAGCCACTTATTGTCTGAGTTGTAATTACTACAGGCTTGTCTTGCTCCCTGGACTTGAGAGTAGGAACTGTCTCATGTCACTTTTGCTAGTCTGTTCTTGCAGCTGTTCTCAACATGTGCAC-T Gestational diabetes mellitus uncontrolled not provided (-)157116
8-50394254-G-A not specified Uncertain significance (Jun 07, 2023)2559276
8-50402238-A-C not specified Uncertain significance (May 16, 2022)2214639
8-50402258-A-C SNTG1-related disorder Likely benign (May 21, 2018)728154
8-50402264-C-T not specified Uncertain significance (Mar 11, 2024)3167096
8-50402265-G-A not specified Uncertain significance (Oct 05, 2023)3167097
8-50402317-T-G not specified Uncertain significance (Jan 06, 2023)2458237
8-50438566-A-G SNTG1-related disorder Likely benign (Apr 03, 2019)3045278
8-50449693-T-G not specified Uncertain significance (Mar 28, 2024)3321232
8-50449698-G-A SNTG1-related disorder Likely benign (Nov 10, 2020)3050595
8-50450556-C-T not specified Uncertain significance (Feb 15, 2023)2464212
8-50450579-A-G not specified Uncertain significance (Dec 27, 2023)3167089
8-50450587-T-C SNTG1-related disorder Likely benign (Jul 16, 2019)3050357
8-50450688-A-T not specified Uncertain significance (Dec 15, 2023)3167090
8-50450727-G-C SNTG1-related disorder Likely benign (Feb 27, 2022)3055929
8-50502773-T-C SNTG1-related disorder Likely benign (Apr 27, 2024)3352405
8-50502799-G-A not specified Uncertain significance (May 17, 2023)2570034
8-50502817-A-G not specified Uncertain significance (Apr 28, 2023)2524126
8-50502836-G-C not specified Uncertain significance (Jan 10, 2023)2457664
8-50502846-T-C SNTG1-related disorder Likely benign (Dec 19, 2023)3031937
8-50530203-A-G not specified Uncertain significance (Sep 21, 2023)3167091
8-50530233-C-T not specified Uncertain significance (Oct 12, 2022)2318496
8-50530239-A-T not specified Uncertain significance (Mar 19, 2024)3321231
8-50530255-A-G not specified Uncertain significance (Mar 24, 2023)2529462
8-50530258-C-G not specified Uncertain significance (Oct 10, 2023)3167092

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SNTG1protein_codingprotein_codingENST00000522124 17884330
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.1630.8371257260211257470.0000835
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.3292892741.060.00001403363
Missense in Polyphen7779.1230.97317971
Synonymous-2.441321011.310.00000537970
Loss of Function3.98832.50.2460.00000155388

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00009080.0000905
Ashkenazi Jewish0.00009960.0000992
East Asian0.0001140.000109
Finnish0.000.00
European (Non-Finnish)0.0001000.0000967
Middle Eastern0.0001140.000109
South Asian0.0001770.000163
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Adapter protein that binds to and probably organizes the subcellular localization of a variety of proteins. May link various receptors to the actin cytoskeleton and the dystrophin glycoprotein complex (By similarity). May participate in regulating the subcellular location of diacylglycerol kinase-zeta to ensure that diacylglycerol is rapidly inactivated following receptor activation. {ECO:0000250}.;

Recessive Scores

pRec
0.115

Intolerance Scores

loftool
0.639
rvis_EVS
0.15
rvis_percentile_EVS
64.74

Haploinsufficiency Scores

pHI
0.226
hipred
Y
hipred_score
0.604
ghis
0.563

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.757

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Sntg1
Phenotype

Gene ontology

Biological process
cell communication
Cellular component
nucleus;cytoplasm;cytoskeleton;dystrophin-associated glycoprotein complex;syntrophin complex;ruffle membrane
Molecular function
actin binding;structural molecule activity;protein C-terminus binding